Adenosine signaling dampens the immune response, thereby promoting tumor survival and metastasis primarily through the CD39/73 axis, though alternative pathways are also present and contribute to the immunosuppressive tumor microenvironment [46,47,48]. The gene discussed is ENTPD1; the disease is neoplasm.